Cinitapride

Cinitapride
Clinical data


Trade names	Cintapro, Pemix
Routes of administration	Oral
ATC code	A03FA08 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-amino-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-ethoxy-5-nitrobenzamide
CAS Number	66564-14-5^Y
PubChem CID	68867
DrugBank	DB08810^Y
ChemSpider	62099^Y
UNII	R8I97I2L24
KEGG	D07700^Y
ChEMBL	CHEMBL2104523^N
Chemical and physical data
Formula	C₂₁H₃₀N₄O₄
Molar mass	402.49 g/mol
Chirality	Racemic mixture
InChI InChI=1S/C21H30N4O4/c1-2-29-20-13-18(22)19(25(27)28)12-17(20)21(26)23-16-8-10-24(11-9-16)14-15-6-4-3-5-7-15/h3-4,12-13,15-16H,2,5-11,14,22H2,1H3,(H,23,26)^Y Key:ZDLBNXXKDMLZMF-UHFFFAOYSA-N^Y
^NY (what is this?)

Cinitapride (trade names Cintapro, Pemix) is a gastroprokinetic agent and antiulcer agent of the benzamide class which is marketed in India, Mexico, Pakistan and Spain. It acts as an agonist of the 5-HT₁ and 5-HT₄ receptors and as an antagonist of the 5-HT₂ receptors.

It is indicated for the treatment of gastrointestinal disorders associated with motility disturbances such as gastroesophageal reflux disease, non-ulcer dyspepsia and delayed gastric emptying.